The recent sale from a key insider at the current share price of US$14.12 raises concerns, despite insiders holding sizable shares in the company. This trend combined with limited recent insider buying causes a cautious outlook towards the company's stock.
Insider sales surpassed insider buying at Avadel Pharmaceuticals in recent months, but yearly transactions are positive. Insider ownership aligns with shareholders, with recent sales not raising major concerns.
Gainers: In reaction to earnings/guidance: •$Silvergate Capital(SI.US)$+10.7% (Silvergate (ticker: SI) notched net income of $38.6 million in the June quarter, delivering earnings per share (EPS) of $1.13.) •$アクソジェン(AXGN.US)$+3.3% (guides Q2 revs above consensus; also makes changes to its commercial organization), •$ノバルティス(NVS.US)$+ 3% (The Swiss pharmaceutical company on Tuesday posted net profit of $1.69 billion, down from...
アバデル・ファーマシューティカルズに関するコメント
読み込み中...
読み込み中...
helloooooo dippy. should run rest of day. 👍🏻
Enjoy your Veterans day and have a blessed weekend.
In reaction to earnings/guidance:
• $ニュータニックス A(NTNX.US)$ +15.4%, $ピュア ストレージ A(PSTG.US)$ +6.8%, $クレド テクノロジー グループ(CRDO.US)$ +5.9%, $シグネット ジュエラーズ(SIG.US)$ +3.6%, $センチネルワン A(S.US)$ +3.4%, $ファイブ ビロウ(FIVE.US)$ +3.2%, $GMS(GMS.US)$ +1.7%, $スコッツ ミラクルグロー(SMG.US)$ +0.9% (also CFO steps down, lowers FY22 FCF guidance, reaffirms all other guidance)
Other news:
• $Turquoise Hill Resources(TRQ.US)$ +12.3% (to be acquired by Rio T...
In reaction to earnings/guidance:
• $Silvergate Capital(SI.US)$ +10.7% (Silvergate (ticker: SI) notched net income of $38.6 million in the June quarter, delivering earnings per share (EPS) of $1.13.)
• $アクソジェン(AXGN.US)$ +3.3% (guides Q2 revs above consensus; also makes changes to its commercial organization),
• $ノバルティス(NVS.US)$ + 3% (The Swiss pharmaceutical company on Tuesday posted net profit of $1.69 billion, down from...
まだコメントはありません